These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3261330)

  • 1. Bone scan flare predicts successful systemic therapy for bone metastases.
    Coleman RE; Mashiter G; Whitaker KB; Moss DW; Rubens RD; Fogelman I
    J Nucl Med; 1988 Aug; 29(8):1354-9. PubMed ID: 3261330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical prediction of response of bone metastases to treatment.
    Coleman RE; Whitaker KB; Moss DW; Mashiter G; Fogelman I; Rubens RD
    Br J Cancer; 1988 Aug; 58(2):205-10. PubMed ID: 3262366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
    Piovesan A; Berruti A; Torta M; Cannone R; Sperone P; Panero A; Gorzegno G; Termine A; Dogliotti L; Angeli A
    Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocalcin: a potential marker of metastatic bone disease and response to treatment.
    Coleman RE; Mashiter G; Fogelman I; Whitaker KD; Caleffi M; Moss DW; Rubens RD
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1211-7. PubMed ID: 3262063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bone alkaline phosphatase in the follow-up of skeletal metastases.
    Zaninotto M; Secchiero S; Rubin D; Sciacovelli L; Trovò M; Bortolus R; Plebani M
    Anticancer Res; 1995; 15(5B):2223-8. PubMed ID: 8572629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P).
    Berruti A; Cerutti S; Fasolis G; Sperone P; Tarabuzzi R; Bertetto O; Pagani G; Zolfanelli R; Pallotti S; Bumma C; Fontana D; Rosseti SR; Dogliotti L; Angeli A
    Anticancer Res; 1997; 17(6D):4697-702. PubMed ID: 9494591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient increase in total serum alkaline phosphatase predicts radiological response to systemic therapy in breast cancer patients with osteolytic and mixed bone metastases.
    Berruti A; Osella G; Raucci CA; Roncari A; Dogliotti L
    Oncology; 1993; 50(4):218-21. PubMed ID: 8497373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase.
    Burlina A; Rubin D; Secchiero S; Sciacovelli L; Zaninotto M; Plebani M
    Clin Chim Acta; 1994 May; 226(2):151-8. PubMed ID: 7923810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
    Stĕpán JJ; Presl J; Broulík P; Pacovský V
    J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of response to therapy of bone metastases in breast cancer.
    Rossleigh MA; Lovegrove FT; Reynolds PM; Byrne MJ; Whitney BP
    Aust N Z J Med; 1984 Feb; 14(1):19-22. PubMed ID: 6235799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteocalcin, a marker in diseases with elevated bone metabolism].
    Stracke H; Schatz C; Pralle H; Ullmann J; Schatz H
    Dtsch Med Wochenschr; 1985 Sep; 110(38):1442-6. PubMed ID: 3875469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing flare in skeletal metastases from breast cancer.
    Janicek MJ; Hayes DF; Kaplan WD
    Radiology; 1994 Jul; 192(1):201-4. PubMed ID: 8208938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer.
    Schneider JA; Divgi CR; Scott AM; Macapinlac HA; Seidman AD; Goldsmith SJ; Larson SM
    J Nucl Med; 1994 Nov; 35(11):1748-52. PubMed ID: 7525900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m HMDP bone scintigraphic findings in association with concurrent serum osteocalcin measurements.
    Shih WJ; Collins J; Wierzbinski B; Magoun S; Ryo UY
    Radiat Med; 1991; 9(4):162-6. PubMed ID: 1961943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity.
    Mayne PD; Thakrar S; Rosalki SB; Foo AY; Parbhoo S
    J Clin Pathol; 1987 Apr; 40(4):398-403. PubMed ID: 3584482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].
    Taue R; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flare response on bone scintigraphy in metastatic prostate cancer].
    Aizawa T; Tochimoto M; Ito T; Tsujino S; Akiyama A; Namiki K; Miki M; Ueda M
    Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):815-8. PubMed ID: 8022146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial bone scans in the assessment of response to therapy in advanced breast carcinoma.
    Rossleigh MA; Lovegrove FT; Reynolds PM; Byrne MJ
    Clin Nucl Med; 1982 Sep; 7(9):397-402. PubMed ID: 7116728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.